Naam |
Afgevaardige namens |
Gilead |
Jansen |
BMS |
Abbvie |
Roche |
MSD |
Overig |
J.E. Arends |
NVHB |
A,R |
A |
A,R |
A,R |
– |
A |
VilV (A,R) |
J.T. Brouwer |
NVH, NVMDL |
A |
A |
A |
A |
– |
A |
– |
M.A.A. Claassen |
NIV |
– |
– |
– |
– |
– |
– |
– |
D.M. Burger |
NVZA |
A,L |
A,L,R |
A,R |
A,L |
R |
A,L,R,C |
– |
J.P.H. Drenth |
NVH, comm Hepatologie NVMDL |
A,C,R |
A |
A |
A,R,C |
– |
A |
Ipsen (R) |
B. van Hoek |
NVH |
– |
A |
A |
A |
– |
A |
Zambon (R), Chiesi (R), Astellas (R), Norgine (A) |
A.I.M. Hoepelman |
NIV |
A, R |
– |
A, R |
– |
– |
A, R |
ViiV (A, R) |
P. Honkoop |
Comm Hepatologie NVMDL |
A |
A |
– |
A |
– |
– |
Will Pharma (A) |
R.J. de Knegt |
NVH/NVMDL |
A,L,R |
A,L,R |
A,L,R |
A,L,R,C |
L,R |
– |
Norgine (A,L), Philip (R) |
P.A.M. Kracht |
NIV |
– |
– |
– |
– |
– |
– |
– |
K. Sebib Korkmaz |
NVMDL/NVH |
– |
– |
– |
– |
– |
– |
|
M.J. Sonneveld |
NVMDL/NVH |
A |
– |
A |
– |
A,L,C |
– |
– |
H. van Soest |
Comm Hepatologie NVMDL |
– |
– |
– |
– |
– |
– |
– |
M. van der Valk |
NVHB |
A,R,L |
A,R |
A |
A |
A |
A,R |
ViiV (A,R) |
S. Willemse |
NVH, NVMDL |
A,L,R,C |
L,R |
A,L,R |
A,R,C |
L,R |
R |
– |